Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03374462 · ClinicalTrials.gov registry record · NA
Type 1 Diabetes Telemedicine
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT03374462 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 59 participants.
The verdict
NCT03374462, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
At the conclusion of this project, investigators will have assessed the effectiveness of home-based telemedicine for improving multiple important clinical and patient-centered outcomes in a high-risk pediatric cohort with T1D. Aim 1. To test the hypothesis that home-based telemedicine is a feasible and acceptable method of care delivery for patients with poorly controlled type 1 diabetes (T1D) currently cared for at the University of California, Davis (UCD) Pediatric Endocrinology clinic. Specifically: A) Patients and families choose to participate in telemedicine visits as a supplement to in-person care; B) Patients and families can utilize secure, internet-based platforms to upload and share glucose meter data and to establish an audio-video connection with a diabetes specialist in their home settings; C) Patients and families are satisfied with the experience of home-based telemedicine and would choose to receive future diabetes care via this modality. Aim 2. To test the hypothesis that using home-based telemedicine, these patients can complete more frequent visits with a diabetes specialist than they previously completed via office visits alone. Aim 3. To test the hypothesis that increased contact with a diabetes specialist via home-based telemedicine will lead to significant improvement in glycemic control for these patients. Aim 4. To evaluate the effects of increased contact with a diabetes specialist via home-based telemedicine on high-cost health care utilization - specifically emergency department (ED) visits and diabetes-related hospitalizations.
Interventions
- BEHAVIORAL Telemedicine Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2019-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03374462
The ClinicalTrials.gov registry entry for NCT03374462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telemedicine Intervention is the first listed.
NCT03374462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03374462 about?
NCT03374462 is a clinical study titled "Type 1 Diabetes Telemedicine". At the conclusion of this project, investigators will have assessed the effectiveness of home-based telemedicine for improving multiple important clinical and patient-centered outcomes in a high-risk pediatric cohort with T1D. Aim 1. To test the hypothesis that home-based telemedicine is a feasible...
What is the current status of trial NCT03374462?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2017-11-27. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03374462?
The interventions under investigation include: Telemedicine Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03374462?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.